-
Medtronic diabetes patient engagement program to offer game-based blood sugar tracking with rewards
fiercebiotech
August 14, 2018
Medtronic launched a new patient engagement program that aims to use game-design elements to encourage people with diabetes to better track their blood glucose levels for improved health outcomes.
-
Medtronic, United receive approval for fully implantable PAH infusion pump
fiercebiotech
August 02, 2018
Medtronic and United Therapeutics received premarket approval from the FDA for a fully implantable drug delivery system that continuously administers Remodulin (treprostinil) through a cardiac catheter to treat pulmonary arterial hypertension.
-
Medtronic Reports Second Quarter Financial Results
biospectrumasia
November 27, 2017
Second quarter revenue increased 3 percent on a comparable, constant currency basis, which adjusts for the divestiture and a $35 million positive impact from foreign currency
-
Medtronic announces FDA Approval and U.S. Launch of Next Generation Pacemakers
biospectrumasia
November 27, 2017
Azure pacemakers feature Medtronic-exclusive BlueSync technology, which enables automatic, secure wireless remote monitoring via the Medtronic CareLink(TM) Network, providing timely alerts of clinically relevant patient events that can be reviewed by a cl
-
Medtronic slows in Q2 but expects growth to pick back up
fiercebiotech
November 23, 2017
Medtronic’s sales took a 4% hit in the second quarter, which the company attributes to the impact of Hurricane Maria on its operations in Puerto Rico, as well as the divestiture of a trio of businesses to Cardinal Health.
-
Johnson & Johnson to close insulin pump businesses
biospectrumasia
October 10, 2017
Medtronic has been a partner-of-choice to help ensure use of insulin pumps for patients who currently use the product.
-
Medtronic’s next generation spinal cord stimulator cleared by FDA
biospectrumasia
September 21, 2017
The world's smallest SCS, the Intellis device offers activity tracking and personalized pain relief
-
Japan MHLW approves Medtronic’s latest device
biospectrumasia
September 13, 2017
IN.PACT Admiral is a clinically proven endovascular therapy that features physical dilatation of the vessel lumen by plain balloon angioplasty.
-
Mazor Robotics to collect another $40M from Medtronic
fiercebiotech
August 31, 2017
Mazor Robotics met sales and marketing milestones ahead of schedule, triggering a third tranche of $40 million from Medtronic, which will assume global distribution rights for Mazor's guidance platform for spine surgeries.
-
Insulet has a challenger for Medtronic on the Horizon
pharmaphorum
June 14, 2017
The rate of innovation in devices for type 1 diabetes patients has accelerated rapidly in recent years, with digital technology and medical devices converging to offer new control.